Azacitidine and Ivosidenib
About
Membership operator: AND
Therapies: 2
Therapies
Azacitidine (tx:ncit:C288)
Ivosidenib (tx:ncit:C114383)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | IDH1 p.R132C | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132G | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132H | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132L | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| EMA (1) FDA (2) | IDH1 p.R132S | Acute Myeloid Leukemia | Azacitidine, Ivosidenib |